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ABSTRACT
Background: Alzheimer’s disease (AD) affects not only memory but also other cognitive functions, such as
orientation, language, praxis, attention, visual perception, or executive function. Most studies on oral com-
munication in AD focus on aphasia; however, speech and orofacial apraxias are also present in these patients.
The aim of this study was to investigate the presence of speech and orofacial apraxias in patients with AD
with the hypothesis that apraxia severity is strongly correlated with disease severity.
Methods: Ninety participants in different stages of AD (mild, moderate, and severe) underwent the following
assessments: Clinical Dementia Rating, Mini-Mental State Examination, Lawton Instrumental Activities of
Daily Living, a specific speech and orofacial praxis assessment, and the oral agility subtest of the Boston
diagnostic aphasia examination.
Results: The mean age was 80.2± 7.2 years and 73% were women. Patients with AD had significantly lower
scores than normal controls for speech praxis (mean difference=−2.9, 95% confidence interval (CI)=−3.3
to −2.4) and orofacial praxis (mean difference=−4.9, 95% CI=−5.4 to −4.3). Dementia severity was
significantly associated with orofacial apraxia severity (moderate AD: β =−19.63, p= 0.011; and severe AD:
β =−51.68, p < 0.001) and speech apraxia severity (moderate AD: β = 7.07, p = 0.001; and severe AD: β =
8.16, p < 0.001).
Conclusion: Speech and orofacial apraxias were evident in patients with AD and became more pronounced
with disease progression.
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Introduction
The overall life expectancy is increasing worldwide.
As older people are typically more vulnerable to
frailty and chronic conditions, such as dementia, a
rise in the incidence and prevalence of Alzheimer’s
disease (AD) is expected (Graham et al.,
1997).
According to the National Institute of Neuro-
logical and Communicative Disorders and Stroke
and the Alzheimer’s Disease and Related Disorders
Association (NINCDS-ADRDA) criteria, the dia-
gnosis of probable AD includes insidious onset
and progressive impairment of memory and other
cognitive functions, such as orientation, language,
praxis, attention, visual perception, and executive
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function (McKhann et al., 1984). Therefore, the
evaluation of cognitive function is a crucial part
of the dementia diagnosis process. Most studies
on oral communication in AD focus on aphasia
(Vuorinen et al., 2000; de Lira et al., 2011); how-
ever, speech and orofacial apraxias are also present
in these patients (Croot et al., 2000; Gerstner
et al., 2007). Aphasia is defined as the acquired
impairment of language processes underlying re-
ceptive and expressive modalities (Akbarzadeh and
Moshtagh-Khorasani, 2007), whereas apraxia is an
impairment in the ability to perform purposeful
movement (Pedretti et al., 1996).
More specifically, speech apraxia is a disturb-
ance that interferes with the capacity to program
the positioning and sequencing of muscle move-
ments for producing phonemes (Darley, 1969), and
orofacial apraxia is a specific type of ideomotor
apraxia in which there is an impairment in the non-
verbal movements of the face, lips, tongue, and
pharynx following a verbal command or imitation
(Broussolle et al., 1996).
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Many aphasic, apraxic, and dysarthric disorders
occur as a result of extensive lesions that impair
multiple cognitive systems resulting in “aphasia
with apraxia of speech” or “apraxia of speech with
dysarthria” (Croot, 2002). Broussolle et al. (1996)
found that orofacial and speech apraxias co-occur
because of the anatomical proximity of structures
involved in their appearance. The authors reported
cortical atrophy mostly restricted to the left frontal
cortex; the anterior operculum and premotor and
sensorimotor cortices were the most affected areas
in a neuroimaging of eight patients who presented
with a clinically recognizable syndrome of progress-
ive speech impairment without dementia (Brous-
solle et al., 1996). Apraxia of speech in stroke cases
can occur due to the left superior precentral gyrus of
the insula (Ogar et al., 2006). In patients with AD
who demonstrate that phonological and articulat-
ory impairments, neuropathological changes were
located in regions of brain frontal, temporal, pari-
etal, and left perisylvian areas (Croot et al., 2000).
There is significant global atrophy in AD (Baron
et al., 2001); therefore, multiple communication
disorders could be expected. As for the brain areas
affected in this disease, Baron et al. (2001) repor-
ted that in mild AD, in approximate decreasing or-
der of statistical significance, gray matter loss affects
the anterior amygdala and hippocampus/entorhinal
cortex areas, the posterior cingulate cortex and adja-
cent precuneus, perisylvian areas, the temporopari-
etal association neocortex, the posterior hippocam-
pus, the anterior hypothalamus and thalamus, the
prefrontal cortex, and the caudate nucleus and puta-
men, with only slight atrophy in the frontal lobe.
Gerstner et al. (2007) presented a case of patholo-
gically proven AD with mood disturbances and pro-
gressive speech loss consistent with speech apraxia.
The postmortem examination disclosed AD patho-
logy in the hippocampal formation, basal nucleus of
Meynert and neocortex with neuritic plaques in the
frontal, occipital, and inferior temporal gyri. Baron
et al. (2001) and Gerstner et al. (2007) showed that
AD affects areas which are also involved in the mani-
festation of speech apraxia, as described by Brous-
solle et al. (1996) and Croot et al. (2000).
In AD, syntactic and semantic linguistic changes
are often studied because they are more evident
and cause greater functional impairment in the pa-
tient’s verbal communication (de Lira et al., 2011)
compared to apraxic manifestations. This approach
seems to contribute to the neglect of studying
speech and orofacial apraxias in AD. Although de-
scribed in patients with definitive diagnosis of AD,
the reports related to speech and orofacial apraxias
in AD are limited to descriptions of cases with focal
presentations of the disease (Kawamura and Moch-
izuki, 1999; Gerstner et al., 2007). In other neuro-
degenerative diseases, such as frontotemporal lobar
degeneration, speech apraxia is one of the most
striking features and results in serious functional
impairment (Ogar et al., 2007). However, speech
and orofacial apraxias should also be considered
in AD, as they limit patients’ oral communication
and may interfere with communication rehabilita-
tion. The current study will be the first to move
from case series descriptions to the investigation of
praxis in a larger sample of patients with AD, which
is especially important when planning strategies for
communication therapy.
The aim of this study was to investigate the pres-
ence of speech and orofacial apraxias in AD patients
and test the hypothesis that apraxia severity is cor-
related to disease severity.
Methods
This was a cross-sectional study of 90 elderly pa-
tients with AD: 30 patients had mild AD, 30 moder-
ate, and 30 severe. Dementia severity was classified
according to the Clinical Dementia Rating (CDR)
scale (Morris, 1993; Montano and Ramos, 2005).
All patients were referred from the outpatient unit of
the behavioral neurology sector of the Department
of Neurology and Neurosurgery of the Federal Uni-
versity of São Paulo.
Ethical approval was granted for this study
(0390/08). Eligible patients or their legal guardi-
ans received information about the study, and those
who gave informed consent were included.
The inclusion criteria were as follows: age 60
years, probable diagnosis of AD according to
the clinical NINCDS-ADRDA criteria (McKhann
et al., 1984), and the presence of an informant. Pa-
tients with mild or moderate AD received thera-
peutic doses of cholinesterase inhibitors (donepezil
5 mg, rivastigmine9 mg, or galantamine8 mg)
(Birks, 2006). Dependency in instrument activities
of daily living (IADL) was confirmed by the Lawton
index (Lawton and Brody, 1969).
The exclusion criteria were as follows: independ-
ence in ADL; a history of alcoholism or use of il-
licit drugs; the use of psychoactive drugs at least
once in the last month, with the exception of atyp-
ical neuroleptic drugs; previous severe neurologic or
psychiatric disease (e.g. epilepsy, carcinoma, schizo-
phrenia); visual or hearing impairments that could
compromise assessment task performance; the ab-
sence of speech or inability to complete the evalu-
ation, as the patient had to be able to respond to the
stimuli presented to allow speech analysis.
All patients were evaluated by a multidiscip-
linary team composed of neurologists, respons-
ible for medical history and physical examination;
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psychologists, responsible for the neuropsycholo-
gical assessment; and a speech therapist who was
responsible for the implementation of the speech
therapy protocol related to this research.
Cognitive assessment
• The CDR adapted by Morris (1993) was used to
classify dementia severity according to the Brazilian
version validated by Montano and Ramos (2005).
• The Mini-Mental State Examination (MMSE),
Brazilian version validated by Brucki et al. (2003),
was employed to evaluate global cognitive function.
• The oral agility subtest of the Boston Diagnostic
Aphasia Examination (BDAE) was used to evaluate
speech and orofacial praxis (Goodglass and Kaplan,
1983). This test includes six tasks of orofacial agil-
ity and seven involving speech agility. The patients’
BDAE scores were compared with the Brazilian
norms of 50 healthy volunteer sample aged 51
years or more (with 7.8± 4.8 of the mean educa-
tional level): 8.7± 2.2 points for orofacial agility
and 12.1± 1.9 for speech agility (Radanovic et al.,
2004). The minimum score is zero and the max-
imum scores for orofacial and speech agility are
12 and 14, respectively. Patients with scores be-
low 7 and 11 were considered as having orofacial
and speech apraxias, respectively.
• To better characterize the participants’ praxis,
speech was also evaluated with the Martins and
Ortiz (M&O) protocol for speech and orofacial
praxis assessment (Martins and Ortiz, 2004). The
orofacial tasks correspond to a range of 0–200
points. Patients with scores below 160 were con-
sidered as having orofacial apraxia. The test com-
prises of the performance of 20 isolated and sequen-
tial movements in response to a verbal command
(e.g. lip protrusion, lateralization of the tongue,
protrusion and retraction of the lips, and later-
alization and elevation of the tongue). When ne-
cessary, the movement was demonstrated by the
examiner; however, the score was reduced when
demonstration was required. The speech assess-
ment in our study includes the repetition of words
and sentences, automatic production, and spon-
taneous speech. In the repetition task, different
length words were used, as well as words that re-
quire either single or multiple places of articula-
tion (e.g. baby, shoes, shoemaker, “The pretty girl
is dancing,” and “The stranger walked along the
road”). The automatic production comprises well-
established sequences of words such as the months
of the year. The spontaneous speech, as sugges-
ted by M&O, used the description of the “Cookie
Theft” figure from the BDAE (Goodglass and Ka-
plan, 1983). For the analysis of speech perform-
ance of all M&O tests, the number and types of
apraxic manifestations observed in the responses
to the M&O protocol were recorded. Patients who
had four or more praxis manifestations in the M&O
were considered as having speech apraxia. The fol-
lowing types of manifestations that are typical of
oral emissions by individuals with apraxia were
observed:
° Substitution: replacement of one phoneme by
another;
° Omission: default of one phoneme or syllable;
° Addition: insertion of one phoneme or syl-
lable to the word;
° Self-correction: spontaneous correction of
apraxic errors;
° Trial and error: sought the articulatory point
of a phoneme or sequence of phonemes in a
bid to perform the correct movement prior to
initiating speech; and
° Repetition: more than one production of
sound, word, part of a word, or utterance.
The proportion of errors was calculated according
to the number of words spoken. However, because
AD patients present speech errors that are also due
to language changes caused by dementia, such as
the frequent repetition of words and phrases relat-
ed to the discursive changes (de Lira et al., 2011),
these linguistic errors were not considered during
the speech analysis. Only repetitions of segments
of words (repetition of sounds or parts of words)
were included for measuring apraxic manifestations.
Moreover, hesitations during spontaneous speech
were disregarded because this characteristic may be
present in the speech of healthy individuals and in
patients with language or speech disorders.
Patient speech was digitally recorded with a
SONY MP3 player and concurrently transcribed.
Speech was transcribed to appropriately classify the
type of error because trial and error can occur
without phonation when the participant seeks the
desired phono-articulatory movement for the phon-
eme without vocalizing.
Statistical methods
We compared our praxis scores with the published
means for healthy participants (Radanovic et al.,
2004) by analyzing the difference between the two
means with one-sample Student’s t-tests.
To verify if dementia and apraxia severity were
significantly related, we performed a multivariate
linear regression with apraxia severity as a depend-
ent variable and dementia severity as an independ-
ent variable. This analysis was controlled by sex,
age, and years of education. The reference group
for comparison was the group of patients with mild
dementia and the scores obtained from the M&O
were analyzed.
A p value of <0.05 was considered statistically
significant. All tests were two tailed. All statistical
analyses were performed with the SPSS statistical
package for Windows, version 17.
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Table 1. Descriptive analysis of the scores on the speech and orofacial praxis tasks by the study group
A D T O T A L M I L D M O D E R A T E SE V E R E
OA SOA OP SP OA SOA OP SP OA SOA OP SP OA SOA OP SP
............................................................................................................................................................................................................................................................................................................................
Mean 3.8 9.2 154.6 11.4 5.6 10.5 177.0 6.0 3.6 9.6 161.3 13.0 2.3 7.6 125.6 15.3
SD 2.6 2.3 34.6 8.8 2.9 1.7 18.6 4.2 1.9 1.6 16.5 6.9 1.8 2.3 40.3 11.1
SD: standard deviation; AD: Alzheimer’s disease; OA: orofacial agility on the Boston Diagnostic Aphasia Examination (BDAE; possible
range: 0–12, higher scores indicating better performance, normative values: 8.7± 2.2); SOA= speech oral agility on the BDAE (possible
range: 0–14, higher scores indicating better performance, normative values: 12.1± 1.9); OP= orofacial praxis component of the Martins
and Ortiz (M&O) protocol (possible range: 0–200, higher scores indicating better performance, and scores below 160 are indicative of
orofacial apraxia); SP= speech praxis component of the M&O (the minimum is zero praxis manifestations, higher scores indicating worse
performance, and more than three praxis manifestations are indicative of speech apraxia).
Table 2. Comparison using Student’s t-test for a single sample among the means of the groups
with AD and data from the literature on normal populations
M E A N
D I FF E R E N C E S
95% CI
(DIFF ERENCE) t p
..................................................................................................................................................................................................................................................................................
AD total
OA −4.9 −5.4 −4.3 − 17.9 <0.001
SOA −2.9 −3.3 −2.4 − 12.1 <0.001
Mild AD
OA −3.1 −4.2 −2.1 − 5.9 <0.001
SOA −1.6 −2.3 −1.0 − 5.2 <0.001
Moderate AD
OA −5.1 −5.8 −4.4 − 14.8 <0.001
SOA −2.5 −3.1 −1.9 − 8.3 <0.001
Severe AD
OA −6.4 −7.1 −5.8 − 20.0 <0.001
SOA −4.5 −5.3 −3.6 − 10.4 <0.001
AD= Alzheimer’s disease; OA= orofacial agility on the Boston Diagnostic Aphasia Examination (BDAE; possible range:
0–12, higher scores indicating better performance, normative values: 8.7± 2.2); SOA= speech oral agility on the BDAE
(possible range: 0–14, higher scores indicating better performance, normative values: 12.1± 1.9).
Results
General characteristics
Out of the 90 individuals participating in the study,
66 were women. Age varied from 64 to 97 years
(mean 80.2± 7.2), and the years of education
ranged from 0 to 12 years (mean 4.2± 3.5). Twelve
participants were illiterate, 56 had 1–4 years of
schooling, nine had 5–8 years, seven had 9–11 years,
and six had over 12 years of schooling; therefore,
76% of patients had less than five years of school-
ing. The mean MMSE score for those with mild
AD was 20.0± 3.4, moderate AD was 14.4± 1.6,
and severe AD was 9.0± 2.9. The mean score on
the Lawton index for patients with mild AD was
7.0± 4.2, with moderate AD was 14.3± 2.0, and
severe AD was 15.4± 1.0.
Descriptive analysis of the praxis scores
Table 1 shows the mean scores for speech and oro-
facial praxis tests in the study groups. Seventy-nine
patients had orofacial apraxia and 81 had speech
apraxia. Only four patients had normal speech and
orofacial praxis. Among the 11 patients with nor-
mal orofacial praxis, 10 were mild cases of AD and
one was of moderate AD. Six out of nine patients
without speech apraxia had mild AD and three had
moderate AD.
Table 2 shows the differences in the means of
orofacial and speech oral agility for patients with
AD (mild, moderate, and severe) and the scores
estimated for the Brazilian population published by
Radanovic et al. (2004). The AD patient means for
the oral agility task were significantly lower than the
scores estimated for the healthy population.
Association between disease severity
and praxis scores controlling for sex,
age, and years of education
According to the multivariate linear regression ana-
lysis using the praxis scores of patients with mild
AD as reference group (Table 3), dementia severity
was significantly associated with orofacial apraxia
severity (moderate AD: β=−19.63, p= 0.011;
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Table 3. Multivariate linear regression analyses to
verify the association between disease severity and
praxis scores (dependent variables) controlling for
sex, age, and years of education
β SE 95% CI (β) p
........................................................................................................................................................
OP
Moderate − 19.63 7.54 − 34.64 − 4.63 0.011
Severe − 51.68 7.21 − 66.02 − 37.35 <0.001
Education 0.15 0.86 − 1.57 1.87 0.862
Sex − 9.56 6.70 − 22.90 3.77 0.157
Age 0.64 0.43 − 0.21 1.49 0.136
SP
Moderate 7.07 1.99 3.11 11.03 0.001
Severe 8.16 1.90 4.38 11.94 <0.001
Education − 0.77 0.23 − 1.23 − 0.32 0.001
Sex 6.24 1.77 2.72 9.76 0.001
Age − 0.19 0.11 − 0.41 0.04 0.103
SE= standard error; OP= orofacial praxis component of the
Martins and Ortiz (M&O) protocol; SP= speech praxis
component of the M&O. Reference group: mild stage of AD.
and severe AD: β=−51.68, p < 0.001) and
speech apraxia severity (moderate AD: β= 7.07,
p= 0.001; and severe AD: β= 8.16, p < 0.001).
This analysis was controlled by sex, age, and years
of education and revealed that speech praxis scores
were influenced by years of education (β=−0.77,
p= 0.001) and sex (β= 6.24, p= 0.001), and oro-
facial praxis scores were not.
Discussion
The main finding in this study was that speech and
orofacial apraxias are nearly always present in AD,
regardless of disease stage, even in patients with
non-focal disease presentation. Moreover, praxis in
patients with AD worsens according to disease stage
(severe and moderate < mild).
There are some previously published reports in-
dicating that praxis scores are worse in patients with
AD compared with normal individuals (Edwards
et al., 1991; Derouesne et al., 2000; Crutch et al.,
2007). However, these studies examined ideatory
and limb apraxias, and they did not include orofacial
and speech praxis assessments. Only a few cases of
speech and orofacial apraxias have been described in
AD (Kawamura and Mochizuki, 1999). This study
observed the apraxias during the clinical evaluation
of patients with primary progressive speech apraxia;
however, AD was diagnosed only after postmortem
examination. Furthermore, patient praxic perform-
ance was not compared with healthy participant per-
formance. The present study evaluated both types
of apraxia in a large sample of patients who were
previously diagnosed with probable AD, and patient
performance was compared with the mean obtained
in a study of healthy Brazilian participants (Radan-
ovic et al., 2004). Cera and Ortiz (2009) showed
that a language’s phonetic–phonological character-
istics can affect speakers’ praxic performance and
should be considered in data analyses. Cognitive
screening must also be analyzed according to what
is expected for the population studied. According
to Brucki et al. (2003), the mean MMSE score for
healthy illiterate participants is 19.5 and for minim-
ally educated 24.8. Since in our sample 13% were
illiterate and 76% had less than five years of formal
education, we expected low MMSE scores even for
patients in the early stage of disease. Although our
results show that speech praxis scores were influ-
enced by educational level, the praxis scores were
significantly associated with disease stage regardless
of education level.
Even though working memory is commonly im-
paired in AD (Belleville et al., 1996), its presence
does not imply speech apraxia, which is an inde-
pendent impairment. The pattern of praxic errors
observed in the present work was similar to that
described in other studies of patients with speech
apraxia of other etiologies (Johns and Darley, 1970;
Canter et al., 1985). Therefore, despite the sus-
ceptibility to interference from working memory
changes on speech praxis performance, the evalu-
ated patients exhibited typical speech apraxia.
In the present study, we observed speech and
orofacial apraxias in the same patients. In a study
by Ogar et al. (2007), orofacial apraxia was present
in 11 out of 18 of speech apraxia patients with
progressive non-fluent aphasia. Thus, the presence
of orofacial apraxia supports the hypothesis that
speech manifestations in AD are, in fact, related to
apraxia, despite interference from working memory
and language. With AD progression, more brain
areas are involved and, therefore, more affected cog-
nitive domains are severely compromised. The in-
volvement of areas adjacent to the precentral gyrus
of the upper left insula was associated with more
severe forms of speech apraxia, as well as the co-
occurrence of apraxia and aphasia (Ogar et al.,
2006). Thus, it is believed that apraxia also wor-
sens with dementia severity.
By correlating speech and orofacial praxis per-
formance with AD severity, we observed that pa-
tients with severe and moderate AD performed sig-
nificantly worse than those in the mild stage of AD
(Table 3). As for the relationship between speech
apraxia and disease severity, Gerstner et al. (2007)
described speech manifestations in an AD case and
showed that they progressed to complete speech
loss.
In the present study, patients with severe AD
had worse praxic performance than the mild group,
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and this was characterized by a higher frequency
of praxic manifestations. Certain types of apraxia
also worsen with dementia severity. Edwards et al.
(1991) evaluated 142 AD patients and reported
that the frequency of patients with ideomotor and
ideational apraxia increased with dementia severity.
In contrast, Crutch et al. (2007) evaluated upper
limb praxis and showed that disease severity was
not necessarily predictive of the presence of this
apraxia. By analyzing the effect of disease severity
on the praxic performance of 33 AD patients (15
mild and 18 moderate), these authors found dif-
ferent results depending on the task assessed (e.g.
transitive gestures, meaningful intransitive gestures,
meaningless intransitive gestures). Thus, they con-
cluded that disease severity only caused interference
for some tasks. The likely differences between their
results and ours may be the distinction of the apraxia
evaluated by Crutch et al. (2007), which evaluated
upper limb apraxia (not speech apraxia), and also
by the sample sizes (33 patients, while this study
evaluated 90 individuals).
One possible explanation for the worsening of the
speech and orofacial apraxias is that, depending on
AD severity, more brain areas are affected, and the
general cognitive framework deteriorates.
There are several limitations that should be con-
sidered when interpreting the results of this study.
The inclusion of patients with severe AD disease
stage that were still able to complete the assessment
tasks may have contributed to the selection of a
sample that minimized differences in speech praxis
scores between the moderate and severe stages. Pa-
tients in the severe AD group, despite having severe
cognitive impairment, had to be able to complete
the tests, and for this reason, the mean MMSE score
(9.0± 2.9) does not correspond to advanced disease
stage patients. Out of 103 patients enrolled, five
(severe stage) were excluded because they stopped
responding to stimuli. Therefore, the standard er-
ror of patients with very severe AD may be differ-
ent from that found in the present study. How-
ever, the presence of a severe reduction or sup-
pression of speech prevented the performance of
speech analysis and did not allow for a compar-
ison of oral praxic performance among the three
disease stages. Thus, the number of errors might
have been overestimated in the mild and moder-
ate stages, which would have increased the likeli-
hood of error due to increased response to stimuli.
Conversely, patients with severe AD who did not
respond to stimuli would show reduced emission
and a consequent absence of error. Another limit-
ation of this study was related to the educational
level; 76% of our participants had less than five
years of formal education. However, we controlled
our analyses for education when verifying the as-
sociation between disease severity and praxis score
controlling.
Although there are descriptions of patients who
focally present with speech and orofacial apraxias
who later receive a diagnosis of AD, we found
speech and orofacial apraxias in the early stages
of the disease. In summary, speech and orofa-
cial apraxias that can be focal or generalized are
frequently present in AD, independent of disease
stage. The recognition of early signs of apraxia in
AD patients might aid in the evaluation of com-
munication difficulties and potentially in developing
rehabilitation strategies.
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